Public Reporting

sport-h 

ACO Name and Location
RWJ Partners LLC
1 Robert Wood Johnson Place
New Brunswick, NJ 08903
ACO Primary Contact
Primary Contact Name Joshua Bershad, MD
Primary Contact Phone Number 732-937-8854
Primary Contact Email Address Joshua.Bershad@RWJBH.org

Organizational Information

ACO Participants
ACO Participants ACO Participant in Joint Venture (Enter Y or N)
Rutgers RWJ Emergency Medicine N
Robert Wood Johnson University Hospital, Inc N
Somerset Medical Center N
Rutgers RWJ Family Medicine N
Rutgers RWJ Pulmonary N
Rutgers RWJ Cardiology N
Rutgers RWJ Rheumatology N
Rutgers RWJ Immunology N
Rutgers RWJ Hem Onc N
Rutgers RWJ Gastroenterology N
Rutgers RWJ Endocrinology N
Allentown Medical Associates N
Rutgers RWJ Department Of Medicine Gen Internal N
Rutgers RWJ Allergy Faculty N
Rutgers RWJ Scleroderma Program N
Rutgers PCC Monument Square N
Rutgers RWJ Primary Care Institute N
Rutgers RWJ Electrophysiology N
Advantage Medical Associates Pa N
RutgersRWJ Primary Medicine Group N
Princeton Medical Care LLC N
Primary Healthcare LLC N
Walk In Medical Center Pc N
Hillsborough Medical Associates, PA N
Robert Wood Johnson Physician Enterprise N
The Whole Istic You LLC N
ACO governing body:
Member Member’s Voting Power Membership Type ACO Participant TIN Legal Business Name
Last Name First Name Title/Position
Abend Paul Voting Member 1 Other – Specialist Representative
Lee Leonard Voting Member 1 ACO Participant Representative Rutgers RWJ Cardiology
Bershad Joshua Vice Chair/Voting Member 1 ACO Participant Representative RWJ Physician Enterprise  PA
Colaizzi John Voting Member 1 Medicare Beneficiary Representative
Gracias Vincente Voting Member 1 ACO Participant Representative Rutgers RWJ Department of Medicine Gen Internal
Malik Bobby Voting Member 1 ACO Participant Representative Princeton Medical Care LLC
Mansue Amy Chair/ Voting Member 1 ACO Participant Representative Robert Wood Johnson University Hospital, Inc.
Moffa Salvatore Voting Member 1 ACO Participant Representative Robert Wood Johnson University Hospital Somerset
Rabadi Khalaf Secretary/Tresurer/ Voting Member 1 ACO Participant Representative Robert Wood Johnson Medical Associates at Hamilton PA
Salwitz Jim Voting Member 1 ACO Participant Representative Robert Wood Johnson University Hospital, Inc.
Key ACO clinical and administrative leadership:
Joshua Bershad ACO Executive
Cathryn Heath Medical Director
Elizabeth Trainor Compliance Officer
Jennifer Smith Quality Assurance/Improvement Officer
Associated committees and committee leadership
Committee Name Committee Leader Name and Position
Board of Managers Amy Mansue, Chair
Finance Committee Amy Mansue, Chair
Performance Improvement Committee Joshua Bershad, Chair
Types of ACO participants, or combinations of participants, that formed the ACO
  • Partnerships or joint venture arrangements between hospitals and ACO professionals

Shared Savings and Losses

Amount of Shared Savings/Losses
  • First Agreement Period
    • Performance Year 2016, $3,912,029
    • Performance Year 2015, $1,827,858
    • Performance Year 2014, $0
Shared Savings Distribution
  • First Agreement Period
    • Performance Year 2016
      • Proportion invested in infrastructure: 35%
      • Proportion invested in redesigned care processes/resources: 15%
      • Proportion of distribution to ACO participants: 50%
    • Performance Year 2015
      • Proportion invested in infrastructure: 35%
      • Proportion invested in redesigned care processes/resources: 15%
      • Proportion of distribution to ACO participants: 50%
    • Performance Year 2014
      • Proportion invested in infrastructure: N/A
      • Proportion invested in redesigned care processes/resources: N/A
      • Proportion of distribution to ACO participants: N/A
Quality Performance Results

2016 Quality Performance Results:


ACO#
Measure Name Rate ACO Mean
ACO-1 CAHPS: Getting Timely Care, Appointments, and Information 79.11 80.51
ACO-2 CAHPS: How Well Your Providers Communicate 94.55 93.01
ACO-3 CAHPS: Patients’ Rating of Provider 94.29 92.25
ACO-4 CAHPS: Access to Specialists 84.04 83.49
ACO-5 CAHPS: Health Promotion and Education 58.96 60.32
ACO-6 CAHPS: Shared Decision Making 74.95 75.40
ACO-7 CAHPS: Health Status/Functional Status 72.07 72.30
ACO-34 CAHPS: Stewardship of Patient Resources 20.79 26.97
ACO-8 Risk Standardized, All Condition Readmission 14.43 14.70
ACO-35 Skilled Nursing Facility 30-day All-Cause Readmission measure (SNFRM) 16.33 18.17
ACO-36 All-Cause Unplanned Admissions for Patients with Diabetes 48.17 53.20
ACO-37 All-Cause Unplanned Admissions for Patients with Heart Failure 70.57 75.23
ACO-38 All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions 52.57 59.81
ACO-9 Ambulatory Sensitive Condition Admissions: Chronic Obstructive Pulmonary Disease or Asthma in Older Adults (AHRQ Prevention Quality Indicator (PQI) #5) 9.69 9.27
ACO-10 Ambulatory Sensitive Conditions Admissions: Heart Failure (AHRQ Prevention Quality Indicator (PQI) #8) 19.13 14.53
ACO-11 Percent of PCPs who Successfully Meet Meaningful Use Requirements 89.09 82.72
ACO-39 Documentation of Current Medications in the Medical Record 95.04 87.54
ACO-13 Falls: Screening for Future Fall Risk 58.29 64.04
ACO-14 Preventive Care and Screening: Influenza Immunization 70.82 68.32
ACO-15 Pneumonia Vaccination Status for Older Adults 72.88 69.21
ACO-16 Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up 72.98 74.45
ACO-17 Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention 95.90 90.98
ACO-18 Preventive Care and Screening: Screening for Clinical Depression and Follow-up Plan 53.47 53.63
ACO-19 Colorectal Cancer Screening 56.14 61.52
ACO-20 Breast Cancer Screening 71.66 67.61
ACO-21 Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented 62.78 76.79
ACO-42 Statin therapy for the Prevention and Treatment of Cardiovascular Disease 70.87 77.72
ACO-27 Diabetes Mellitus: Hemoglobin A1c Poor Control 24.58 18.24
ACO-41 Diabetes: Eye Exam 45.29 44.94
ACO-28 Hypertension (HTN): Controlling High Blood Pressure 62.16 70.69
ACO-30 Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic 81.59 85.05
ACO-31 Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD) 90.43 88.67
ACO-33 Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy – for patients with CAD and Diabetes or Left Ventricular Systolic Dysfunction (LVEF<40%) 75.36 79.67
Please note, the ACO-40 Depression Remission at 12 months quality measure is not included in public reporting due to low samples.

Note: In the Quality Performance Results file(s) above, search for “RWJ Partners LLC” to view the quality performance results. This ACO can also be found by using the ACO ID A18812 in the public use files on data.cms.gov.

Payment Rule Waivers

No, our ACO does not use the SNF 3-Day Rule Waiver.